Influenza B virus B/Washington/02/2019 antigen (formaldehyde inactivated)

DB15620ApprovedInvestigationalVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2019
Brand names
  • Fluzone High-Dose Quadrivalent
  • Fluzone Quadrivalent

Resolves to

Compound
UNIIVEH9U90EHX
Clinical / RWD
RxNorm2280293

What you can answer from here — as of April 02, 2025

13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
48Marketed productsAcross 5 countries and 11 labellers
Sign in

Which companies are running trials of Influenza B virus B/Washington/02/2019 antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In